Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Grupo Ferrer acquires Alexza for up to $55mm

Executive Summary

Per a non-binding letter of intent, private Spanish company Grupo Ferrer Internacional SA aims to acquire all shares of public US biotech Alexza Pharmaceuticals Inc. (CNS therapeutics) that it doesn't already own.

Deal Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Contract
    • Includes Earnout
    • Partial Acquisition
    • Payment Includes Cash

Related Companies